HEXO to acquire Redecan for $766m.

HEXO, a medical cannabis company, agreed to acquire Redecan, a Canadian cannabis company, for $766m. “Redecan’s unwavering focus on the consumer, along with lean operating principles and highly efficient automated manufacturing technology, have allowed us to establish a significant presence in the Canadian market. We’ve now entered a phase where scale is key, and our complementary consumer bases, brand portfolios and distribution relationships can enhance financial performance," Will Montour, Redecan Co-Founder.